David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
HCA Healthcare
HCA
$92.7B
| $922K | ﹤0.01% |
6,237
-40,546
| -87% | -$5.44M |
|
|
CAMP
3002
DELISTED
CalAmp Corp.
CAMP
| $922K | ﹤0.01% |
4,183
-9,109
| -69% | -$2.22M |
|
|
GHL
3003
DELISTED
Greenhill & Co., Inc.
GHL
| $922K | ﹤0.01% |
54,000
+26,190
| +94% | +$425K |
|
3004
Forestar Group
FOR
$1.47B
| $921K | ﹤0.01% |
44,154
-1,459
| -3% | -$28.5K |
|
|
ROIC
3005
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $918K | ﹤0.01% |
51,975
-105,702
| -67% | -$1.91M |
|
|
ROCC
3006
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $914K | ﹤0.01% |
30,100
| – | – |
|
3007
PUT
Madrigal Pharmaceuticals
MDGL
$12.3B
| $911K | ﹤0.01% |
10,000
-10,000
| -50% | -$970K |
|
3008
PUT
Methanex
MEOH
$4.43B
| $908K | ﹤0.01% |
23,500
-20,000
| -46% | -$750K |
|
3009
StoneX
SNEX
$8.25B
| $908K | ﹤0.01% |
94,092
+29,186
| +45% | +$242K |
|
|
CHNG
3010
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $907K | ﹤0.01% |
55,319
+36,319
| +191% | +$487K |
|
3011
PUT
Capital One
COF
$133B
| $906K | ﹤0.01% |
8,800
-4,300
| -33% | -$414K |
|
3012
Columbia Banking Systems
COLB
$8.72B
| $906K | ﹤0.01% |
22,277
-8,481
| -28% | -$330K |
|
3013
PUT
RLI Corp
RLI
$5.98B
| $900K | ﹤0.01% |
20,000
| – | – |
|
|
STEL
3014
DELISTED
Stellar Bancorp
STEL
| $897K | ﹤0.01% |
28,831
+15,316
| +113% | +$449K |
|
3015
Grupo Cibest SA
CIB
$23.6B
| $894K | ﹤0.01% |
+16,310
| New | +$843K |
|
|
ARA
3016
DELISTED
American Renal Associates Holdings, Inc
ARA
| $892K | ﹤0.01% |
86,029
-1,125
| -1% | -$9.62K |
|
|
RDUS
3017
CALL
DELISTED
Radius Health, Inc.
RDUS
| $891K | ﹤0.01% |
44,200
| – | – |
|
|
ARD
3018
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $890K | ﹤0.01% |
45,432
+13,110
| +41% | +$241K |
|
3019
Hilton Worldwide
HLT
$74.7B
| $889K | ﹤0.01% |
8,017
-2,745
| -26% | -$275K |
|
3020
Corporacion America
CAAP
$4.07B
| $886K | ﹤0.01% |
147,652
+84,767
| +135% | +$380K |
|
|
GMS
3021
DELISTED
GMS Inc
GMS
| $883K | ﹤0.01% |
32,602
-175,098
| -84% | -$5.14M |
|
3022
PUT
Incyte
INCY
$26.2B
| $882K | ﹤0.01% |
10,100
| – | – |
|
3023
Motorcar Parts of America
MPAA
$217M
| $878K | ﹤0.01% |
39,836
-33,955
| -46% | -$656K |
|
3024
PUT
Xerox
XRX
$391M
| $878K | ﹤0.01% |
23,800
| – | – |
|
3025
American States Water
AWR
$3.55B
| $873K | ﹤0.01% |
10,081
-9,267
| -48% | -$821K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.